ADMA Biologics
ADMA
ADMA
251 hedge funds and large institutions have $2.03B invested in ADMA Biologics in 2024 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 88 increasing their positions, 83 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.41% more ownership
Funds ownership: 76.69% → 78.09% (+1.4%)
6% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 83
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
251
Holding in Top 10
6
Calls
$12.7M
Puts
$527K
Top Buyers
| 1 | +$60M | |
| 2 | +$22.5M | |
| 3 | +$20.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.4M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$17.9M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$27.9M | |
| 3 | -$17.9M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$17.4M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$17.2M |